PlainPharmaWatch

CMS Open Payments · Program Year 2024

Medunik USA Inc.

Medunik USA Inc. reported $2,137.13 across General Payments, Research, and Ownership to 52 physicians and teaching hospitals across 52 transactions.

See the rankings → How this is sourced
$2.1K
All-tracks total
52
Transactions
52
Recipients
#1790
of 1,925 companies

Medunik USA Inc. reported $2,137.13 across all CMS Open Payments tracks (General + Research + Ownership) to 52 physicians and teaching hospitals in Program Year 2024 - ranking #1790 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $2,137.13, averaging $41.10 per recipient.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the publisher.

CMS Sunshine Act warrant

Manufacturer medunik-usa-inc Medunik USA Inc.

$2.1K · #1790/1,925 · 0.0% industry · PY2024

  • TOT $2.1K
  • RANK #1790
  • SHARE 0.0%
  • TXN 52
  • RCP 52
  • CAT 2
  • GEN $2.1K
  • TOP1 46.8%
  • PY 2024

Volume peers

Nearest volume peer: Thermo Fisher Scientific Asheville LLC ($2.2K)

Dymicron$2.3KThermo Fisher Scientific Ash…$2.2KMedunik USA Inc. (this)$2.1KVision Quest Industries Inc.$2.1KAmerican National Red Cross$2.1K
All-tracks payment totals near Medunik USA Inc. (CMS Open Payments PY2024)

Medunik USA Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

What the Data Shows for Medunik USA Inc.

In Program Year 2024, Medunik USA Inc. reported $2,137.13 in payments to 52 physicians and teaching hospitals across 52 individual transactions, an average of $41.10 per transaction and $41.10 per recipient. That total places Medunik USA Inc. at rank #1790 out of 1,925 companies in the CMS Open Payments database, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

49 transactions worth $1.1K make "Food and Beverage" the top general-payment category in the 2-category breakdown below, 53.2% of General Payments (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

"Food and Beverage" leads Medunik USA Inc.'s 2-category general-payment breakdown at $1.1K, 53.2% of the reported total.

How Medunik USA Inc. divides its payments

Top payment categories by total reported dollar volume

1. Food and Beverage$1.1K2. Consulting Fee$1.0K
Payment Type Amount Transactions
Food and Beverage $1.1K 49
Consulting Fee $1.0K 3

Recipient Concentration in General Payments

The five largest recipient relationships account for $1,172.16 (54.8%) of $2,137.13 in this company's General Payments records across 47 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Medunik USA Inc.

The five named recipients with the highest reported General Payments from this company

Holly Bernal$1.0KAbigail J Cruz$49.23Brandon Chalazan$45.70Tarachandra M Narumanchi$42.03Manisha M Bansal$35.20
  1. 1

    Holly Bernal

    $1,000.00 across 3 reported transactions

  2. 2

    Abigail J Cruz

    $49.23 across 2 reported transactions

  3. 3

    Brandon Chalazan

    $45.70 across 2 reported transactions

  4. 4

    Tarachandra M Narumanchi

    $42.03 across 2 reported transactions

  5. 5

    Manisha M Bansal

    $35.20 across 1 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as Medunik USA Inc.'s, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Medunik USA Inc..

Advanced Bionics, LLC

HHI 2255

Cg Medtech USA, Inc

HHI 2257

Leica Microsystems (Schweiz) AG

HHI 2261

BioWound Solutions, Inc.

HHI 2261

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with Medunik USA Inc..

Showing 6 of 1,924 companies with CMS-reported payment data.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Medunik USA Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.